Cargando…
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
AIM: To evaluate the effectiveness of empagliflozin in clinical practice in East Asia in the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) East Asia study. MATERIALS AND METHODS: Data were obtained from the Medical Data Vision database (Japan), National Health Insurance Service databa...
Autores principales: | Seino, Yutaka, Kim, Dae Jung, Yabe, Daisuke, Tan, Elise Chia‐Hui, Chung, Wook‐Jin, Ha, Kyoung Hwa, Nangaku, Masaomi, Node, Koichi, Klement, Riho, Yasui, Atsutaka, Lei, Wei‐Yu, Lee, Sunwoo, Kyaw, Moe H., Deruaz‐Luyet, Anouk, Brodovicz, Kimberly G., H.‐H. Sheu, Wayne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831226/ https://www.ncbi.nlm.nih.gov/pubmed/33532619 http://dx.doi.org/10.1002/edm2.183 |
Ejemplares similares
-
Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study
por: Kim, Dae Jung, et al.
Publicado: (2023) -
Healthcare resource utilization in patients treated with empagliflozin in East Asia
por: Sheu, Wayne H‐H, et al.
Publicado: (2022) -
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care
por: Patorno, Elisabetta, et al.
Publicado: (2019) -
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
por: Vistisen, Dorte, et al.
Publicado: (2023) -
Rheumatology in East Asia
por: Yamamoto, Kazuhiko, et al.
Publicado: (2018)